Research Article

Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism

Table 2

Correlations of the brain SPECT with 99mTc-TRODAT-1 of the groups with Parkinsonism.

VariablesSynucleinopathies (SNP) (SNP) (PD × MSA) (PD × LBD)Tauopathies (TP) (TP) (TP × SNP) (TP × PD)DIP (19) (DIP × SNP) (DOP × PD)VP (13) (VP × SNP) (VP × PD)
PD (93)MSA (7)LBD (16)PSP (2)CBD (3)

Regarding normality (%)93 (100%)7 (100%)16 (100%)12 (100%)3 (100%)11111 (57.9%)<0.0001<0.000110 (77.0%)<0.00010.0001
Abnormal exam
Severity of the alterations
 Normal or zero0 (0%)0 (0%)0 (0%)0.1990.2090.8140 (0%)0 (0%)0.7640.6850.8638 (42.1%)<0.0001<0.00013 (23.1%)<0.0001<0.0001
 Mild reduction or 11 (1.1%)1 (14.3%)0 (0%)0 (0%)0 (0%)4 (21.1%)2 (15.4%)
 Moderate reduction or 219 (20.4%)1 (14.3%)3 (18.7%)1 (50%)1 (33.3%)7 (36.8%)3 (23.1%)
 Accentuate reduction or 356 (60.2%)4 (57.1%)8 (50%)0 (0%)2 (66.7%)0 (0%)5 (38.5%)
 Severe reduction or 417 (18.3%)1 (14.3%)5 (31.3%)1 (50%)0 (0%)0 (0%)0 (0%)
Symmetry of the abnormal (%)
 Asymmetric77 (82.6%)6 (85.7%)13 (81.3%)0.99910.9991 (50%)3 (100%)0.4000.9740.7138 (42.1%)<0.0001<0.00016 (46.2%)<0.0001<0.0001
 Symmetric16 (17.2%)1 (14.3%)3 (18.7%)1 (50%)0 (0%)3 (15.8%)4 (30.8%)
 Normal0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)8 (42.1%)3 (23.1%)
Laterality symptoms
 Unilateral89 (95.7%)6 (85.71%)13 (81.25%)0.0510.3090.0631 (50%)3 (100%)0.4000.0360.10514 (73.78%)0.0280.0068 (61.53%)0.0020.001
 Left35 (37.6%)1 (14.3%)8 (50%)0 (0%)2 (66.7%)5 (26.3%)2 (15.4%)
 Right54 (58.1%)5 (71.4%)5 (31.3%)1 (50%)1 (33.3%)9 (47.4%)6 (46.2%)
 Undefined—bilateral4 (4.3%)1 (14.3%)3 (18.8%)1 (50%)0 (0%)5 (26.3%)5 (38.5%)
Laterality-SPECT-TRODAT
 Unilateral76 (81.72%)6 (87.71%)13 (81.25%)0.999111 (50%)3 (100%)0.4000.3940.71711 (57.9%)0.2270.0336 (46.2%)0.0650.009
 Left43 (46.2%)3 (42.9%)7 (43.8%)1 (50%)0 (0%)8 (42.1%)5 (38.5%)
 Right33 (35.5%)3 (42.9%)6 (37.5%)0 (0%)3 (100%)3 (15.8%)1 (7.7%)
 Undefined—bilateral17 (18.3%)1 (14.3%)3 (18.8%)1 (50%)0 (0%)8 (42.1%)7 (53.8%)
Laterality corresponding to the most affected side (%)
 Yes68 (73.18)5 (71.42)11 (68.75)0.689 (sim × não) 0.041 (bilat × contra)1 (sim × não) 0.306 (bilat × contra)0.508 (sim × não) 0.052 (bilat × contra)2 (100%)2 (66.6%)1 (sim × não) 1 (bilat × contra)0.807 (sim × não) 0.059 (bilat × contra)0.938 (sim × não) 0.254 (bilat × contra)17 (89.5%) (89.47%)0.566 (sim × não) <0.0001 (bilat × contra)1 (sim × não) <0.0001 (bilat × contra)11 (84.6%) (84.61%)0.824 (sim × não) <0.0001 (bilat × contra)0.508 (sim × não) <0.0001 (bilat × contra)
  Contralateral64 (69%)4 (57.1%)8 (50%)1 (50%)2 (66.66%)6 (31.6%)4 (30.86%)
  Bilateral4 (4.3%)1 (14.3%)3 (18.75%)1 (50%)0 0%)11 (58%)7 (53.8%)
 No25 (26.9%)2 (28.6%)2 (12.5%)0 (0%)1 (33%)2 (10.5%)2
  Ipsilateral9 (9.7%)1 (14.3%)2 (12.5%)0 (0%)1 (33.33%)1 (5.26%)0 (0%)
  Undefined16 (17.2%)1 (14.3%)00 (0%)0 (0%)1 (5.26%)2 (15.4%)

PD: Parkinson’s disease, MSA: multiple system atrophy, LBD: Lewy body dementia, SNP: synucleinopathies, TP: tauopathies, PSP: progressive supranuclear palsy, CBD: cortico-basal degeneration, DIP: drug-induced Parkinsonism, VP: vascular Parkinsonism, RLS: restless legs syndrome, RSBD: REM sleep behavioral disorder, DRSBD: duration of REM sleep disorder. p<0.05 indicated statistical significance.